Index. Erythematotelangiectatic rosacea (ETR), Espana, A., 204

Transcription

1 A Acne excoriee, 21, 22 Acneiform disorders, 340 Acne keloidalis nuchae (AKN), 340 description, 130 diagnosis, 131, 132 differential diagnosis, 133 epidemiology, histopathology, 133 laser hair removal, 244 pathogenesis, 131 prevalence, treatment first line therapy, minimally invasive therapy, 135 surgical, 135 Acne vulgaris (AV) aggravating factors, 23 clinical features, epidemiology, management oral therapy, 27 procedural therapy, topical therapy, pathogenic factors, 23 PIH, 22 vs. rosacea, 29 sequelae, 28 Acupuncture traditional Asian practice, cutaneous conditions adverse effects, 311 description, 309 evaluation process, 310 psoriasis, 310 Adrian, R.M., 229 AE. See Anagen effluvium (AE) African American community cocoa butter, 302 diagnosis codes, dermatologist visit, 301 hair myths, 303 patient care, 304 skin myths, African descent, cultural considerations description, 300 health services utilization, misconceptions, 301 AGA. See Androgenetic alopecia (AGA) Aging effects, ethnic skin, AKN. See Acne keloidalis nuchae (AKN) Alaluf, S., 6 Alexis, A.F., 23 Alopecia areata, Alopecia syphilitica, Alpha hydroxy acids, Alster, T., 197 Anagen effluvium (AE), 99 Androgenetic alopecia (AGA), 97 98, Antimalarials lupus erythematosus, 55 sarcoidosis, 71 Aramaki, J., 10 Aromatherapy, traditional Asian practice alopecia areata, 309 contact dermatitis, 309, 310 description, 307 phototoxic reaction, 309 Ashy dermatosis. See Erythema dyschromicum perstans (EDP) Asian skin irritants and allergens, 40 structure and physiology, 39 A.F. Alexis and V.H. Barbosa (eds.), Skin of Color: A Practical Guide to Dermatologic Diagnosis and Treatment, DOI / , Springer Science+Business Media New York

2 372 Atopic dermatitis (AD) characterization, 45 differential diagnosis, 48 distribution and morphology, 45, 46 epidemiology, 47 feature, 45, 46 histopathology, 47 incidence, 47 laboratory findings, 47 pathophysiology, 47 pediatric diseases, children of color criteria, 332 Dennie-Morgan folds, 332, 333 differential diagnosis, 335, 336 features, 331 lichenification, 332, 333 lichenoid, 333 skin care, treatment, 333 therapy, 48, 49 Autoimmune diseases alopecia areata, 99 children of color, 347 Autologous minigraft technique, 174 Autologous thin Thiersch graft technique, 174 AV. See Acne vulgaris (AV) cosmetic applications, 265 cosmetic procedure, 263 description, 263 dynamic wrinkles, facial shaping, dermal fillers, history, 265 injection technique, photoaging, pre and postoperative care, 266 serotypes, 263 side effects, 272 treatment guidelines axillary hyperhidrosis, 271 bunny lines, 269, 270 chin lines, 270, 271 Crow s feet, 269, 270 eyelid ptosis, 271 forehead lines, 269 Glabellar lines, 268 lateral browlift, 269 Marionette lines, Botwood, N., 198 Bowen s disease, 215 Brown, D.L., 80 Bulengo-Ransby, S., 149 Busquets, A., 201 B Bacterial-derived hyaluronic acid, 251 Ballow, M., 46, 48 Basal cell carcinoma (BCC) atypical presentation, 212 differential diagnosis, 213, 214 nodular-pigmented, 213 Battle, E.F., Jr., 240 Bayat, A., 189 Berardesca, E., 4, 9, 10 Berman, B., 200, 201 Berman, N., 200 Bernard, B.A., 7 Beta hydroxy acid, Black skin irritants and allergens, 40 structure and physiology, 39 Bleomycin, 204 Botulinum toxin A (BtxA) action mechanism, 266 aging process, Botox vs. Dysport, 263, 264 clinical use, 265 commercial preparations, 266 complications, 272 contraindications, 267 C Canella, A., 277 CCCA. See Central centrifugal cicatricial alopecia (CCCA) Cell layers, 5 Central centrifugal cicatricial alopecia (CCCA) clinical features, epidemiology, 107 etiology, 107 features, 106, 107 hair transplants, ethnic populations, previous names, 106 treatment, Chan, L.S., 46, 49 Chan, R., 143 Chemical peels benefits, 283, 286 description, 280 peeling agents, classification of, 280 risks, 280, 283 Child, F.J., 24 Children of color autoimmune diseases, 347 description, 327

3 genetic disorders, 347 inflammatory diseases, metabolic syndrome, pediatric diseases atopic dermatitis, confluent and reticulated papillomatosis, 339 follicular disorders, nickel allergic contact dermatitis, 338 pigmentary disorders, pityriasis rosea, 337 psoriasis, 338 seborrheic dermatitis, 337 pigmentary alteration causes, skin development linear pigmentation, 330, 331 melanocyte migration, melanosomes, 329 Mongolian spots, 330 transient neonatal pustular melanosis, 330 Voight/Futcher s lines, 331 Choi, S., 225 Chronic cutaneous lupus erythematosus, 115, 116 Chua, S.H., 231 Chuangsuwanich, A., 201 Cicatricial alopecias lymphocytic CCCA, chronic cutaneous lupus erythematosus, 115, 116 LPP, neutrophilic DCS, FD, North American Hair Research Society (NAHRS) classification, 106 Classic lichen planopilaris (LPP), Clostridium botulinum, 263 Coin rubbing/coining technique, 311 Comedone extraction, acne vulgaris, 27 Conejo-Mir, J.S., 197 Confluent and reticulated papillomatosis, 339 Contact dermatitis allergens, clinical presentation, 39 description, 37 epidemiology, patch testing, Corcuff, P., 5 Corneocyte variability, 5 Corticosteroids acne keloidalis nuchae, keloids polytherapy, 192 side effects, solo therapy, uses of, 190 pityriasis alba, 164 sarcoidosis, 70 Cosman, B., 182 Cosmetic concerns advantages, 222 disadvantages, 222 DPN, 228, 229 hyperpigmentation description, 222 diffuse, 224 facial, 223 localized, treatment therapies, keloids, skin laxity description, 231 infrared tightening, radiofrequency (RF), 231 unwanted hair removal diode laser, 229 Nd:YAG system, topical eflornithine HCl, 228 Crespo-Erchiga, V., 83 Cupping technique, Cutaneous needle, 309 D DCS. See Dissecting cellulitis of the scalp (DCS) Deep chemical peels, 296 Dermal-epidermal junction (DEJ), 3 Dermal fillers, ethnic skin aging effects, cosmetic products growth, 247 PLLA, soft tissue augmentation, Dermal structure, 7 8 Dermatosis papulosa nigra (DPN), 228, 229 Dermis, 3 De Winter, S., 7, 11 Diffuse hyperpigmentation, 224 Discoid lupus erythematosus (DLE), 115,

4 374 Disorders of hyperpigmentation melasma cheeks/nose/forehead, 140 clinical diagnosis, clinical recommendations, description, 139 etiology, 140 histologic patterns, 141 laser and light therapy, peeling agents, topical agents, US preventive services task force grade definitions, 146, 148 nevus of Ito, nevus of Ota classification, 153 clinical diagnosis, clinical recommendations, 154 description, 151 etiology, 152 histopathology, 153 Q-switched laser therapy, 154 periorbital hypermelanosis clinical diagnosis, 155 description, 155 etiology, 155 histopathology, 155 recommendations, 156 treatment, PIH clinical diagnosis, 148, 149 clinical recommendations, description, 148 etiology, 148 histopathology, peeling agents, 150 topical agents, Dissecting cellulitis of the scalp (DCS), DLE. See Discoid lupus erythematosus (DLE) DPN. See Dermatosis papulosa nigra (DPN) Dreschnack, P., 256 Duncan, M., 200 Durani, P., 189 E Earles, R.M., 355 Earlobe keloids, Ear needle, 309 Ellgehausen, P., 51 Epidermis, 3 Erythema dyschromicum perstans (EDP), 344 Erythematotelangiectatic rosacea (ETR), Espana, A., 204 F Fabbri, P., 56 Facial lipoatrophy grading scale, 256, 257 injection technique, 257 safety and efficacy history, treatment sessions, 257 Faergemann, J., 78 Falabella, R., 163 Farber, E.M., 60 FD. See Folliculitis decalvans (FD) Fernandez-Faith, E., 65, 66, 70 Fibrosing Alopecia in a Pattern Distribution (FAPD), 111, 112 Filiform steel needle, 309 Fitzpatrick, R., 202, 203, fluorouracil (5-FU), Florencio, V.D., 83 Flores, F., 200 Flores-Hughes, G., 319 Follicular disorders, Folliculitis decalvans (FD), Foot corrections, Fox, 280 Fox, H., 163 Foy, V., 10 Frank, J.E., 80 Frontal fibrosing alopecia (FFA), 111 G Galadari, I., 240 Garg, V.K., 144, 150 Genetic disorders, 347 George, A.O., 131 González, L.M., 57, 59 Gottlieb, A.B., 63, 64 Grabski, W., 196 Graham Little syndrome, 112 Granstein, R., 200 Grant-Kels, J.M., 332 Granulomatous rosacea, 30 Griffith, B., 191 Grimes, P.E., 142, 222, 289 Grooming-induced alopecias, Guerra, L., 171 Gunjittisomram, S., 201 Gupta, A.K., 78, 83

5 Gupta, S., 202 Guy, R.H., 9 H Hair characteristics African ancestry, 351, 352 Asian populations, 351, 352 Caucasians, 351, 352 curved hair follicle, 352 racial/ethnic populations, 353 Hair myths, African American community, 303 Hair transplantation, ethnic populations AGA, anesthesia, 361 CCCA, complications, 365, 366 consultation, contraindications, 360 donor harvesting, emerging technologies, 367 eyebrows, 366, 367 eyelashes, 366 graft preparation, historical perspective, postoperative counseling, 366 recipient site creation, 365 surgical instrumentation, 361, 362 TA, 357, 358 Halder, R.M., 23, 24 Hall, H.I., 302 Hanifin, J.M., 332 Hanke, J., 256 Har-Shai, Y., 202 Hebra, F., 280 Henna, Herbal medicine, traditional Asian practice atopic dermatitis, Bowen s disease, 307, 308 macular hypopigmentation, 307, 308 psoriasis, 307 Herzberg, A.J., 133 Hirayama, T., 153 Hirsutism, 243 Hispanic patient challenge, 325 classification, 320 culture in US, familism, 321 folk illness, health beliefs, 321 history, lack of health insurance, 323, mestizo, 320 mulattos, 320 personalism, 321 terminology, 319 HMF. See Hypopigmented mycosis fungoides (HMF) Hobbs, L.M., 240 Hochberg, M.C., 52 Hyaluronic acid, soft tissue augmentation bacterial-derived, 251 description, enhancement precautions, 251, 253 overview, 251, 252 viscoelastic, 251 Hyperpigmentation description, 222 diffuse, 224 facial, 223 localized, treatment therapies, Hypertrichosis, 243 Hypopigmentation/depigmentation disorders idiopathic guttate hypomelanosis causative factors, 162 characterization, 162 cryotherapy, description, 161 differential diagnosis, 162 localized superficial dermabrasion, 163 psychological effects, 162 oculocutaneous albinism 2B clinical phenotype, 169 description, differential diagnosis, ocular manifestations, 169 photoprotection, 170 piebaldism characteristic manifestation, 170 c-kit proto-oncogene, 170 description, 170 differential diagnosis, 171 histopathologic examination, 171 leukoderma, 170 repigmentation, 171 PIH, pityriasis alba characterization, 163 description, 163 differential diagnosis, 164 tar emulsions, 165 treatment, variations, 164 xerosis, 164

6 376 Hypopigmentation/depigmentation disorders (cont.) progressive macular hypomelanosis, vitiligo autoimmune pathogenesis, 172 autologous minigrafts, 174 autologous thin Thiersch graft, 174 clinical variants, 172 depigmentation, description, 172 diagnosis, 172 excimer laser therapy, 174 narrowband UVB, 173 psoralen photochemotherapy, 174 PUVA therapy, 173, 174 response rates, 175 suction blister grafts, 174 topical corticosteroids, 173 types, 172 Hypopigmented mycosis fungoides (HMF), 216, 217 I Idiopathic guttate hypomelanosis (IGH) causative factors, 162 characterization, 162 cryotherapy, description, 161 differential diagnosis, 162 localized superficial dermabrasion, 163 psychological effects, 162 IGH. See Idiopathic guttate hypomelanosis (IGH) Imiquimod application, Inflammatory diseases, Inflammatory disorders atopic dermatitis characterization, 45 differential diagnosis, 48 distribution and morphology, 45, 46 epidemiology, 47 feature, 45, 46 histopathology, 47 incidence, 47 laboratory findings, 47 pathophysiology, 47 therapy, 48, 49 lichen planus annular lesions, 48 bullous, 50 characterization, 48 description, 48 differential diagnosis, 51 drugs and contactants, 50, 51 epidemiology, 50 erosive/ulcerative, 50 histopathology, 51 hypertrophic, 49 pathophysiology, 50 systemic illness, 50 treatment, 52 lupus erythematosus description, 52 differential diagnosis, 55 epidemiology, 54 histopathology, 54 laboratory findings, 55 pathophysiology, 54 skin disorders and morphology, 52, 53 treatment, pityriasis rosea description, 56 differential diagnosis, 58, 59 drugs associated, 59 epidemiology, 58 etiology, 58 histopathology, 58 treatment, 59 variants of, 56, 57 psoriasis age variation, 61 description, 60 differential diagnosis, 62 epidemiology, histopathology, 61 pathophysiology, 61 systemic agents, 63 topical agents, 63 topical vs. systemic/phototherapy, 62 treatment, 62 triggers, 60 sarcoidosis description, 62 differential diagnosis, 66, 70 epidemiology, erythema nodosum, 68 etiology, 69 histopathology, 69 hypopigmented macules, 66, 67 laboratory findings, 69 lupus pernio, 67, 68 micropapular, 66, 67 morphologic variants, 65 treatment, scleroderma description, 71

7 377 differential diagnosis, 75 divisions, 71 epidemiology, etiology, 73 histopathology, 74 laboratory findings, 74 treatment, seborrheic dermatitis description, 76 differential diagnosis, 77 epidemiology, 77 etiology, 77 Malassezia species, 76 petaloid seborrhea, 76 therapeutic options, 77, 78 syphilis annular, 79 description, 78 differential diagnosis, 80 epidemiology, 79 laboratory, 80 treatment, 81 tinea (pityriasis) versicolor black skin, 81, 82 description, 81 differential diagnosis, 83 epidemiology, 81 etiology, laboratory, 83 prevalence, 81 therapeutic options, 84 Intralesional corticosteroids acne vulgaris, 27 lupus erythematosus, 56 Intralesional verapamil, 203 J Jessner s solution, Joshi, S.S., 150 K Kagami, S., 154 Kaidbey, K.H., 10 Kal, H., 198 Kamiishi, H., 199 Kaposi, M., 130 Katta, R., 65 Kaufman, J., 201 Kawasaki disease, 346 Kaya, T.I., 162 Keloids, avoidance behaviors, bleomycin, 204 combination therapy, 204 compression therapy, 199 corticosteroids polytherapy, 192 side effects, solo therapy, uses of, 190 cryotherapy, 202 earlobe, 188 epidemiology, etiology endocrine factors, 184 genetic predisposition, 184 infection, 184 skin tension, 183 trauma, 183 features, fluorouracil (5-FU), vs. hypertrophic scars, 185, 186 imiquimod application, interferons, intralesional verapamil, 203 Medermar, 203 mobility reduction, 186, 187 pathogenesis, 185 radiation therapy, silicone gel sheeting (SGS), 200 surgical therapy earlobe keloids, general rules of thumb, 194 laser, 197 therapeutic options, 189 tightening and pulling, 186, 187 vitamin E, Kerner, J., 265 Kiil, J., 191 Kligman, A.M., 142 Koebner phenomenon, 48 Kormeili, T., 60, 61 Kosaka, M., 199 Kumar, B., 202 Kunachak, S., 144 L Lancet/blood letting needle, 309 Lane, J., 184 Laser hair removal, darker skin types AKN, 244 appropriate laser parameters, consultation, hirsutism, 243 hypertrichosis, 243

8 378 Laser hair removal, darker skin types (cont.) laser device choice, vs. lighter skin patients, 237 paradoxical hypertrichosis, 245 patient selection, 241 PFB, 244 safety, 239, 240 side effects, 243 test spots, treatment, Latino patients, cultural considerations. See Hispanic patient Lautenschlager, S., 80 Lebwohl, M., Leder, R.O., 60 Leventhal, D., 189 Lichen planopilaris (LPP) clinical features, epidemiology, features, 110 pathogenesis, 113 subgroups, 110 treatment, Lichen planus annular lesions, 48 bullous, 50 characterization, 48 description, 48 differential diagnosis, 51 drugs and contactants, 50, 51 epidemiology, 50 erosive/ulcerative, 50 histopathology, 51 hypertrophic, 49 pathophysiology, 50 systemic illness, 50 treatment, 52 Lip rejuvenation, Lo Brutto, R., 277 Localized hyperpigmentation, Lupus erythematosus description, 52 differential diagnosis, 55 epidemiology, 54 histopathology, 54 laboratory findings, 55 pathophysiology, 54 skin disorders and morphology, 52, 53 treatment, Lymphocytic cicatricial alopecias CCCA clinical features, epidemiology, 107 etiology, 107 features, 106, 107 previous names, 106 treatment, chronic cutaneous lupus erythematosus, 115, 116 LPP clinical features, epidemiology, features, 110 pathogenesis, 113 subgroups, 110 treatment, M Mahmoud, B.H., 141 Malhotra, A., 201 Malignant melanoma, 214, 216 Marini, 277 Marley, B., 214 Marshman, G., 50 Martin-Garcia, R., 201 McCauliffe, D.P., 53, 55, 56 McDonnell, J., 65, 66, 70 Mederma, 203 Medium-depth chemical peels applying technique, classification, 293 contraindications, 295 glycolic acid, 296 indications, trichloroacetic acid (TCA), 295 Melaleuca alternifolia. See Tea tree Melanin/Melanosomes, 6 7 Melanocyte and fibroblast reactivity, 275 Melanoma, E.M., 325 Melanonychia striata, 330 Melasma cheeks/nose/forehead, 140 clinical diagnosis, clinical recommendations, description, 139 etiology, 140 histologic patterns, 141 laser and light therapy, peeling agents, topical agents, US preventive services task force grade definitions, 146, 148 Melasma quality-of-life scale (MELASQOL), 141 Metabolic syndrome,

9 Methotrexate lichen planopilaris, sarcoidosis, 71 Microdermabrasion benefits, 279 vs. dermabrasion, 276 description, 276 procedure, Mongolian spots, 330 Moxibustion technique, 312, 313 Mustoe, T., 189 Mycobacterium fortuitum infection, 313, 314 N Neutrophilic cicatricial alopecias DCS, FD, Nevus fuscoceruleus ophthalmomaxillaris. See Nevus of Ota Nevus of Ito, Nevus of Ota classification, 153 clinical diagnosis, clinical recommendations, 154 description, 151 etiology, 152 histopathology, 153 Q-switched laser therapy, 154 Nickel allergic contact dermatitis, 338 Nodulocystic acne, 23 Nonmelanoma skin cancers (NMSC), 212 Nonscarring alopecias alopecia areata, alopecia syphilitica, anagen effluvium, 99 androgenetic alopecia, grooming-induced alopecias, primer on hairstyling, relaxer-induced alopecia, telogen effluvium, traction alopecia, 96, 97 trichotillomania, O Ocular rosacea, 30 Oculocutaneous albinism 2B clinical phenotype, 169 description, differential diagnosis, ocular manifestations, 169 photoprotection, 170 Oculodermal melanocytosis. See Nevus of Ota Okuda, S., 353, 354 Orentreich, N., 353, P Papulopustular rosacea (PPR), 30 Paradoxical hypertrichosis, 245 Pathak, M.A., 141 Periorbital hypermelanosis clinical diagnosis, 155 description, 155 etiology, 155 histopathology, 155 recommendations, 156 treatment, Periorificial (perioral) dermatitis, 340 Peterson, J.D., 46, 49 PFB. See Pseudofolliculitis barbae (PFB) ph, 5 Photoaging Botulinum toxin type A (BTX-A), soft tissue augmentation, Phymatous rosacea, 30 Piebaldism characteristic manifestation, 170 c-kit proto-oncogene, 170 description, 170 differential diagnosis, 171 histopathologic examination, 171 leukoderma, 170 repigmentation, 171 Pierce, H.E., 353, 354 Pigmentary disorders, Pigmentary mosaicism, 331 PIH. See Postinflammatory hyperpigmentation (PIH) Pityriasis alba characterization, 163 description, 163 differential diagnosis, 164 tar emulsions, 165 treatment, variations, 164 xerosis, 164 Pityriasis rosea description, 56 differential diagnosis, 58, 59 drugs associated, 59 epidemiology, 58

10 380 Pityriasis rosea (cont.) etiology, 58 histopathology, 58 pediatric diseases, children of color, 337 treatment, 59 variants of, 56, 57 Pityriasis versicolor, 77, 78. See also Tinea (pityriasis) versicolor Poly-L-lactic acid (PLLA) characteristics, 255 description, 254 effective use, 256 facial lipoatrophy, 256, 257 hydrogel, injection steps, 258, 260 safety, 254 Pomade acne, 23 Postinflammatory hyperpigmentation (PIH) acne vulgaris, 22 clinical diagnosis, 148, 149 clinical recommendations, description, 148 etiology, 148 histopathology, peeling agents, 150 seborrheic dermatitis, 167, 168 topical agents, PPR. See Papulopustular rosacea (PPR) Progressive macular hypomelanosis, Pseudofolliculitis barbae (PFB) description, 123 differential diagnosis, 124, 126 epidemiology, 123 etiology, 124 keloidal/hypertrophic scarring, 124, 126 laboratory investigations, 124 laser hair removal, 244 pathogenesis, 124 PIH, 124, 126 prevalence, 123 sample patient education material, 128 treatment chemical peels, 130 epilation, first-line therapy, 127 hair removal practices, medical therapy, 129 Pseudopelade of Brocq, 112 Psoriasis age variation, 61 description, 60 differential diagnosis, 62 epidemiology, histopathology, 61 pathophysiology, 61 pediatric diseases, children of color, 338 systemic agents, 63 topical agents, 63 topical vs. systemic/phototherapy, 62 treatment, 62 triggers, 60 R Rajka, G., 331, 332 Reed, J.T., 8, 9 Relaxer-induced alopecia, Relyveld, G.N., 167 Rijken, F., 11 Robinson, J.K., 302 Rosacea vs. acne vulgaris, 29 African-American woman, 31 clinical features, description, 28 epidemiology, management laser and light therapy, oral therapy, 32 topical therapy, 32 Rothe, M.J., 332 Rothifeld, N., 53, 56 S Sak yant, 312 Salasche, S., 196 Salicylic acid peels acne, 27 cheek, 226 hyperpigmentation disorders, 144, 150, 151 PIH, 27 Sarcoidosis description, 62 differential diagnosis, 66, 70 epidemiology, erythema nodosum, 68 etiology, 69 histopathology, 69 hypopigmented macules, 66, 67 laboratory findings, 69 lupus pernio, 67, 68 micropapular, 66, 67 morphologic variants, 65 treatment, Sarkar, 287 Scarring alopecias. See Cicatricial alopecias SCC. See Squamous cell carcinoma (SCC) Schulze, R., 129

11 Scleroderma description, 71 differential diagnosis, 75 divisions, 71 epidemiology, etiology, 73 histopathology, 74 laboratory findings, 74 treatment, Seborrheic dermatitis (SD) description, 76 differential diagnosis, 77 epidemiology, 77 etiology, 77 Malassezia species, 76 pediatric diseases, children of color, 337 petaloid seborrhea, 76 therapeutic options, 77, 78 Selective photothermolysis, 238 Shaffer, J., 189 Silicone gel sheeting (SGS), 189, 192, 200 Skin biophysical properties, 4 5 cancers BCC, histologic differences, HMF, 216, 217 malignant melanoma, 214, 216 ozone layer, 212 SCC, screening and prevention, treatment options, cell layers, 5 corneocyte variability, 5 cultural differences, functional differences barrier function, 8 9 blood vessel, 9 10 cutaneous appendages, percutaneous absorption, 8 9 photoprotection, skin reactivity, 9 10 vitamin D production, laxity description, 231 infrared tightening, radiofrequency (RF), 231 myths, African American community, resurfacing procedures (see Chemical peels; Microdermabrasion) structure and function, 2 3 Soft tissue augmentation hyaluronic acid bacterial-derived, 251 description, enhancement precautions, 251, 253 overview, 251, 252 viscoelastic, 251 photoaging, soft tissue fillers, blacks, 250 stimulatory fillers, Sontheimer, R.D., 51, 75 Sperling, L.C., 131 Squamous cell carcinoma (SCC), Stashower, M., 201 Steen, V.D., 72 Stoughton, R.B., 9 Stratum corneum, 2, 6 Stulberg, D.L., 59 Suction blister graft technique, 174 Sunenshine, P.J., 78 Superficial chemical peels acne, 27 alpha hydroxy acids, beta hydroxy acid, Jessner s solution, PIH, 27 tretinoin, trichloroacetic acid (TCA), Syphilis annular, 79 description, 78 differential diagnosis, 80 epidemiology, 79 laboratory, 80 treatment, 81 Systemic sclerosis (SSc) American College of Rheumatology guidelines, 71 anterior chest depigmentation, 72, 73 differential diagnosis, 75 pathogenetic mechanisms, 73 pigmented lesions, 74 prevalence, 72 skin changes, 71, 72 types, 71 Szabo, G., 10 T TA. See Traction alopecia (TA) Talakoub, L., 2 Tan, E.M., 52 Taylor, S., 142 TE. See Telogen effluvium (TE) Tea tree, Telogen effluvium (TE), Tinea capitis, Tinea (pityriasis) versicolor 381

12 382 Tinea (pityriasis) versicolor (cont.) black skin, 81, 82 description, 81, 343 differential diagnosis, 83 epidemiology, 81 etiology, laboratory, 83 prevalence, 81 therapeutic options, 84 Traction alopecia (TA) in childhood, 339, 340 classic pattern, 96, 97 female pattern hair loss, 357, 358 Traditional Asian practice, cutaneous conditions acupuncture adverse effects, 311 description, 309 evaluation process, 310 psoriasis, 310 aromatherapy alopecia areata, 309 contact dermatitis, 309, 310 description, 307 phototoxic reaction, 309 coin rubbing/coining technique, 311 common beliefs, 314 cupping technique, henna, herbal medicine atopic dermatitis, Bowen s disease, 307, 308 macular hypopigmentation, 307, 308 psoriasis, 307 moxibustion technique, 312, 313 sak yant, 312 Transepidermal water loss (TEWL), 4 Trichloroacetic acid (TCA) medium-depth chemical peels, 295 superficial chemical peels, Trichorrhexis nodosa, 339 Trichotillomania (TTM), Trindade, F., 154 Tyndall effect. See Mongolian spots U Unna, 280 V Veen, R., 198 Viscoelastic hyaluronic acid, 251 Vitamin E, Vitiligo autoimmune pathogenesis, 172 autologous minigrafts, 174 autologous thin Thiersch graft, 174 clinical variants, 172 depigmentation, description, 172 diagnosis, 172 excimer laser therapy, 174 narrowband UVB, 173 psoralen photochemotherapy, 174 PUVA therapy, 173, 174 response rates, 175 suction blister grafts, 174 topical corticosteroids, 173 types, 172 Voight/Futcher s lines, 331 W Wang, C.C., 145 Wang, H.W., 154 Warrier, A.G., 5 Wasserbauer, N., 46, 48 Watanabe, S., 154 Water content (WC), 4 5 Watkins, D.B., 163 Weaver, S.M., 129 Wesley, N.O., 2 White spot parapsoriasis description, 84 differential diagnosis, 85 epidemiology, 85 etiology/pathophysiology, 85 histopathology, 85 laboratory findings, 85 treatment, 86 Wickham s striae, 48 Wickrema, W.J., 9 Wiley, J., 153 Williams, C., 197 Willis, I., 142 Wilson, D., 4 Wolff, K., 72, 75 Wolfrey, J., 59 Y Yamaguchi, Y., 11 Yantra tattooing. See Sak yant